Skip to content

InvestNot yet confirmed elsewhere1 publisher3 min readPublished Updated

Rocket One's AI rename lifted a going-concern stock toward $2 on a chip that exists only as a licensed design

Hoth Therapeutics renamed itself Rocket One in May to make AI chips for satellites, two months after its auditor doubted it could survive. Its stock went from under $1 to nearly $2 on a licensed chip design that has not been built, the story-first pitch that cost SPAC buyers most of their money.

The Investor · Invest desk

How we use AISend a correction

Illustration accompanying Rocket One's AI rename lifted a going-concern stock toward $2 on a chip that exists only as a licensed design
Generated illustration
2021 SPAC buyers kept $274 per $1,000; market gave $1,165 Average value three years later of $1,000 put into a 2021 SPAC merger company at its first-day close, against the same sum in the broad stock market.

Bar comparison: $1,000 invested in a company that merged with a SPAC in 2021, bought at the end of its first trading day, was worth about $274 three years later on average; the same $1,000 in the broad stock market grew to about $1,165.

2021 SPAC buyers kept $274 per $1,000; market gave $1,165 (Value three years on of $1,000 invested in 2021, on average)
ItemValueClaim
Company merged with a SPAC in 2021274 USD11
Broad stock market1,165 USD11

What happened

  • Rocket One says it holds an exclusive license to a chip design that runs AI calculations with magnetism instead of electrons in silicon, and plans to sell to small-satellite and defense customers.
  • Jay Ritter's figures show $1,000 put into a 2021 SPAC merger at the end of its first trading day was worth about $274 three years later, against about $1,165 in the broad market.
  • SEC rules in force since July 2024 make a SPAC disclose sponsor pay, conflicts, dilution and the assumptions behind its projections before holders vote on a merger.
  • Those rules cover only SPACs and similar companies that list with no business of their own, so they do not reach a listed drug developer that changes its name.

Why it matters

  • exposure Rocket One's holders are pricing a satellite-chip business with no required disclosure of the forecasts behind it and no merger vote at which to turn it down.
  • cost If Rocket One raises cash to answer its auditor's doubts, existing holders pay through dilution, and the post-rename price sets how much of the company each dollar raised costs them.
  • precedent Dozens of AI renames show a listed company can take a SPAC-style story to market through a route the 2024 disclosure rules leave open.

The SPAC losses began in the share structure. A SPAC listed as a shell holding cash, typically at $10 a share, according to an SEC investor bulletin [8]. Yale researchers Michael Klausner, Michael Ohlrogge and Emily Ruan found that by the time a typical one merged, it had about $5.70 of cash behind each share [9]. A buyer at $10 was getting 57 cents of cash per dollar, a $4.30 gap per share before the target business had done anything [16]. Much of that gap went to sponsors, whose founder shares almost always equalled a quarter of the public shares and may have cost them next to nothing [10]. Divide a quarter by one and a quarter and the sponsors held 20% of the combined share count [17].

The SPAC comparison is weakest on that point. A Rocket One holder owns part of a company that was already trading on Nasdaq [7] plus an exclusive license to a magnetic chip design [3]. A name change has no obvious equivalent of the dilution a SPAC builds in at listing. The comparison holds on timing. In both cases the price moved before there was anything to sell, and according to Quartz, Rocket One has no commercial product [5].

I think the share price matters to Rocket One mostly as a way to raise cash. The company's auditor raised "substantial doubts" about whether it could stay in business [2]. The Seoul Economic Daily reported the stock at nearly $2 after the rename. At that price, selling stock raises a given sum with roughly half the new shares it would have taken below $1 [18]. Quartz's account does not say whether Rocket One has sold any.

If the magnetic design gets built and qualified, buyers near $2 were early, and the rename priced a real product before it shipped. A share sale at the higher price would pay for that work and leave holders the upside on a smaller slice of the company. The third path is the one 2021's SPAC mergers took. At least 21 companies that listed through SPACs went bankrupt in 2023 alone, including WeWork, Lordstown Motors and Proterra, and their shareholders lost more than $46 billion from peak values, according to Bloomberg data [12]. I'd expect the share sale first, because a company its auditor doubts has to find cash before it can build a chip. The case that the rename sold only a story is wrong the day Rocket One shows a working device, or names a company or agency that has qualified it.

When the SEC adopted its SPAC rules, Gary Gensler, then the agency's chair, said: "Just because a company uses an alternative method to go public does not mean that its investors are any less deserving of time-tested investor protections." [14] Rocket One was already listed, so it needed no merger to become a satellite-chip company [7].

What to watch

  • Any Rocket One sale of shares or warrants after the rename, and the price it sets against the sub-$1 level before the name change.
  • A report that the magnetic chip has been built as a working device, scheduled for a space test, or qualified by a satellite or defense buyer.
  • Any SEC move to extend its July 2024 SPAC disclosure rules to listed companies that change business through a rename.

Clarity's read

What the record supports and how the coverage leans. The claims behind it follow.

Reality

Evidence55
Adoption2
Hype gap+75
Incentives70
Confidence55
Why these scores

Claim ledger

Ranked by verification strength, evidence, and original report placement.

  1. [1]

    In May, Hoth Therapeutics, a Hoboken, N.J., company developing cancer drugs, renamed itself Rocket One and told investors it would build AI chips for satellites.

    ReportedSupportedSource: QuartzView cited source
  2. [2]

    The rename came two months after Hoth's auditor raised "substantial doubts" about whether the company could stay in business.

    ReportedSupportedSource: QuartzView cited source
  3. [3]

    Rocket One says it has the exclusive license to a chip design that uses magnetism, instead of electrons moving through silicon, to run AI calculations, and plans to sell AI hardware for small satellites and defense customers.

    ReportedSupportedSource: Rocket One, via QuartzView cited source

Sources

1 independent publisher whose own reporting we read for this story.

  1. qz.com

    1 article · October 9, 2026

    AI rebrands sell stories, not products. The same pitch cost SPAC investors billions

Share your take

Let Clarity write the post for you.

Signed-in readers get a short post drafted on this story in the register they choose — narrative, analytical, or a direct position — editable to the last word before it goes anywhere. The share buttons at the top of this story work without an account.

Topics and entities

Follow any of these and your For You feed starts watching them — no settings page required.

Topics

Loading related stories